[
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0001",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 24
    },
    "stem": "下列有關血壓測量的敘述，何者錯誤?",
    "options": [
      {
        "key": "A",
        "text": "小腿與上臂的血壓差增加常見於重度主動脈閉鎖不 全 (aortic regur郾tation) 或嚴重下肢周邊血管疾病"
      },
      {
        "key": "B",
        "text": "小腿的收縮壓通常比上臂的收縮壓高 20 m1nHg"
      },
      {
        "key": "C",
        "text": "血壓袖帶的長度和寬度應分別為手臂圓周的 80% 和 40% 。 使用不合適的小袖帶，會導致對 實際血塵值明顯低估"
      },
      {
        "key": "D",
        "text": "兩側上臂的收縮血壓差距，正常應在 !OnunHg 以內"
      }
    ],
    "answer": "C",
    "explanation": "若袖帶過小，通常會使所測得的血壓高估（因為需要更高壓\n力才能完全壓迫動脈），而非低估 。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0002",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 25
    },
    "stem": "下列有關糖尿病與高血壓的敘述，何者錯誤？",
    "options": [
      {
        "key": "A",
        "text": "糖尿病病人的高血壓盛行率較沒有糖尿病者高"
      },
      {
        "key": "B",
        "text": "糖尿病病人罹患高血壓的首選控制血壓藥物為 angiotensin-converting enzyme inh心tors 或是an giotensin receptor blockers"
      },
      {
        "key": "C",
        "text": "糖尿病病人的血壓控制目標通常建議比沒有糖 尿病的患者來得寬鬆"
      },
      {
        "key": "D",
        "text": "高血糜會促進糖尿病的大血管與小血管病變的 發生及惡化"
      }
    ],
    "answer": "C",
    "explanation": "糖尿病患者的血壓控制目標通常較一般人嚴格 ，以減少大血\n管和微血管併發症的風險。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0003",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 25
    },
    "stem": "下列針對主動脈縮窄 (coarctation of the aorta) 的敘述，何者錯誤？",
    "options": [
      {
        "key": "A",
        "text": "狹窄處最常見於左鎖骨下動脈後方、動脈導管 (ductus arteriosus) 開口對側"
      },
      {
        "key": "B",
        "text": "年幼嬰兒可表現為心衰竭或 shock，常合併 PDA"
      },
      {
        "key": "C",
        "text": "可造成上肢高血壓、下肢血壓較低與股動脈搏動減弱"
      },
      {
        "key": "D",
        "text": "典型胸部 X 光可見 rib notching 與 figure of 3 sign"
      }
    ],
    "answer": "A",
    "explanation": "主動脈縮窄典型狹窄位於左鎖骨下動脈分支處附近，常在動\n脈導管附著區域；題目 A 的描述位置不恰當。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0004",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 26
    },
    "stem": "下列對於高血壓急症 (hypertensive emergency) 的敘述，何者正確？",
    "options": [
      {
        "key": "A",
        "text": "只要血壓大於 180/120 mmHg 即可診斷，不需終末器官傷害"
      },
      {
        "key": "B",
        "text": "應在數分鐘內將血壓降至正常，以避免腦出血"
      },
      {
        "key": "C",
        "text": "需要合併急性終末器官傷害，通常需靜脈降壓並監測"
      },
      {
        "key": "D",
        "text": "可使用舌下短效 nifedipine 作為常規急救用藥"
      }
    ],
    "answer": "C",
    "explanation": "高血壓急症重點在於「急性終末器官傷害」(如腦、心、腎、\n主動脈剝離等)；需靜脈降壓並監測，避免過快降壓與避免短效\nnifedipine。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0005",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 27
    },
    "stem": "下列何者不是原發性醛固酮增多症 (primary aldosteronism) 常見特徵？",
    "options": [
      {
        "key": "A",
        "text": "高血壓合併低血鉀"
      },
      {
        "key": "B",
        "text": "代謝性鹼中毒"
      },
      {
        "key": "C",
        "text": "血漿腎素活性上升"
      },
      {
        "key": "D",
        "text": "可對 MRA（如 spironolactone）反應良好"
      }
    ],
    "answer": "C",
    "explanation": "原發性醛固酮增多症常見：高血壓、低血鉀、代謝性鹼中毒、\n腎素被抑制（低），且對 MRA 有效。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0006",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 28
    },
    "stem": "關於 24 小時動態血壓監測 (ABPM) 的敘述，下列何者正確？",
    "options": [
      {
        "key": "A",
        "text": "ABPM 無法評估夜間血壓"
      },
      {
        "key": "B",
        "text": "夜間血壓下降 10-20% 稱為 dipper，屬正常生理"
      },
      {
        "key": "C",
        "text": "non-dipper 代表較低的心血管風險"
      },
      {
        "key": "D",
        "text": "ABPM 僅能用於已確診高血壓者，不適用於白袍高血壓評估"
      }
    ],
    "answer": "B",
    "explanation": "ABPM 可監測夜間血壓與節律；正常人夜間血壓下降 10-20%\n（dipper）。non-dipper 反而與較高心血管併發症風險相關；\nABPM 也可用於白袍/隱匿性高血壓評估。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0007",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 29
    },
    "stem": "下列何者為妊娠期高血壓治療中應避免使用的藥物？",
    "options": [
      {
        "key": "A",
        "text": "Methyldopa"
      },
      {
        "key": "B",
        "text": "Labetalol"
      },
      {
        "key": "C",
        "text": "ACE inhibitor / ARB"
      },
      {
        "key": "D",
        "text": "Hydralazine"
      }
    ],
    "answer": "C",
    "explanation": "妊娠期高血壓常用 methyldopa/labetalol/hydralazine；ACEi/ARB\n（以及 DRI）為妊娠禁忌（胎兒腎毒性/畸胎風險）。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0008",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 30
    },
    "stem": "下列關於 resistant hypertension 的敘述，何者最恰當？",
    "options": [
      {
        "key": "A",
        "text": "定義為使用 1 種降壓藥仍無法達標"
      },
      {
        "key": "B",
        "text": "常與鹽皮質激素（醛固酮）機轉相關，加用 MRA 可能有效"
      },
      {
        "key": "C",
        "text": "與生活型態無關"
      },
      {
        "key": "D",
        "text": "不需評估繼發性高血壓原因"
      }
    ],
    "answer": "B",
    "explanation": "頑固型高血壓需考慮服藥依從性、白袍效應、生活型態與繼發性\n原因；不少患者與醛固酮相關，MRA（如 spironolactone）常有效。"
  },

  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0009",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 31
    },
    "stem": "下列何者最符合高血壓治療中 thiazide 類利尿劑的特性？",
    "options": [
      {
        "key": "A",
        "text": "常造成高血鉀"
      },
      {
        "key": "B",
        "text": "可增加尿酸，可能誘發痛風"
      },
      {
        "key": "C",
        "text": "主要用於急性肺水腫第一線"
      },
      {
        "key": "D",
        "text": "對骨質沒有影響"
      }
    ],
    "answer": "B",
    "explanation": "Thiazide 可能造成低血鉀、低鈉、增加尿酸（痛風風險）、高血糖等；\n在高血壓為常用第一線之一。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0010",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 32
    },
    "stem": "下列何者最符合 ACE inhibitor 可能造成的不良反應？",
    "options": [
      {
        "key": "A",
        "text": "乾咳與血管性水腫"
      },
      {
        "key": "B",
        "text": "嚴重低血鈣"
      },
      {
        "key": "C",
        "text": "甲狀腺機能亢進"
      },
      {
        "key": "D",
        "text": "嚴重中性球增多"
      }
    ],
    "answer": "A",
    "explanation": "ACEi 常見副作用：乾咳、血管性水腫、高血鉀、腎功能惡化（特別是雙側腎動脈狹窄）。"
  },

  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0011",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 33
    },
    "stem": "關於 dihydropyridine (DHP) 類 CCB，下列何者較正確？",
    "options": [
      {
        "key": "A",
        "text": "以抑制房室結傳導為主"
      },
      {
        "key": "B",
        "text": "較常造成周邊水腫與反射性心搏過速"
      },
      {
        "key": "C",
        "text": "可用於控制心房顫動心室率為首選"
      },
      {
        "key": "D",
        "text": "對血管平滑肌作用很弱"
      }
    ],
    "answer": "B",
    "explanation": "DHP 類以血管擴張為主，常見副作用包括周邊水腫、潮紅、頭痛，\n短效製劑更容易引起反射性心搏過速。"
  },

  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0012",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 34
    },
    "stem": "下列何者最適合描述 non-DHP 類 CCB（verapamil/diltiazem）的作用？",
    "options": [
      {
        "key": "A",
        "text": "主要增加心肌收縮力"
      },
      {
        "key": "B",
        "text": "主要降低心率並抑制房室結傳導"
      },
      {
        "key": "C",
        "text": "主要用於治療低血壓"
      },
      {
        "key": "D",
        "text": "與心臟傳導無關"
      }
    ],
    "answer": "B",
    "explanation": "Non-DHP 類 CCB 主要影響心臟傳導系統（尤其 AV node），可降心率、\n抑制傳導，並具有負性變力作用。"
  },

  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0013",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 35
    },
    "stem": "下列何者最符合 β 阻斷劑具有 ISA (intrinsic sympathomimetic activity) 的意義？",
    "options": [
      {
        "key": "A",
        "text": "具有部分致效作用，靜息心率下降較少"
      },
      {
        "key": "B",
        "text": "完全沒有心臟相關副作用"
      },
      {
        "key": "C",
        "text": "更適合心肌梗塞後長期預後改善"
      },
      {
        "key": "D",
        "text": "可作為急性肺水腫首選"
      }
    ],
    "answer": "A",
    "explanation": "ISA 代表部分致效活性，因此靜息時心率下降較少；在需強力交感抑制（如 MI 後）通常偏好無 ISA 的 β 阻斷劑。"
  },

  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0001",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "關於 24 小時動態血壓監測（ABPM）之夜間血壓節律（dipping），下列何者最正確？",
    "options": [
      {
        "key": "A",
        "text": "正常人夜間血壓通常上升 10–20%（dipper）"
      },
      {
        "key": "B",
        "text": "夜間血壓下降 10–20% 稱為 dipper，與較低心血管風險相關"
      },
      {
        "key": "C",
        "text": "non-dipper（夜間未下降）通常代表較低心血管風險"
      },
      {
        "key": "D",
        "text": "ABPM 無法評估夜間血壓"
      }
    ],
    "answer": "B",
    "explanation": "ABPM 可監測夜間血壓；正常生理為夜間相對日間下降約 10–20%（dipper）。若夜間未下降（non-dipper）代表節律異常，與較高心血管併發症風險相關。",
    "tags": [
      "hypertension",
      "ABPM"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0002",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "量測血壓時袖帶（cuff）尺寸的原則，下列何者正確？",
    "options": [
      {
        "key": "A",
        "text": "袖帶寬度約為上臂圓周的 10%，長度約為 20%"
      },
      {
        "key": "B",
        "text": "袖帶寬度與長度分別約為上臂圓周的 40% 與 80%"
      },
      {
        "key": "C",
        "text": "袖帶過小會使量到的血壓偏低估"
      },
      {
        "key": "D",
        "text": "袖帶過大會使量到的血壓偏高估"
      }
    ],
    "answer": "B",
    "explanation": "正確袖帶尺寸：寬度約為上臂圓周 40%，長度約為 80%。袖帶過小通常會高估血壓（需要更高壓力才能壓迫動脈），過大則可能低估。",
    "tags": [
      "hypertension",
      "blood pressure measurement"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0003",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "妊娠高血壓/子癲前症需要降壓治療時，下列何者較符合常用且相對安全的降壓藥選擇？",
    "options": [
      {
        "key": "A",
        "text": "ACE inhibitor"
      },
      {
        "key": "B",
        "text": "ARB"
      },
      {
        "key": "C",
        "text": "Methyldopa"
      },
      {
        "key": "D",
        "text": "Direct renin inhibitor (aliskiren)"
      }
    ],
    "answer": "C",
    "explanation": "妊娠相關高血壓常用 methyldopa、labetalol、hydralazine。ACEi/ARB/DRI 具胎兒腎毒性與畸胎風險，為妊娠禁忌。",
    "tags": [
      "hypertension",
      "pregnancy",
      "pharmacology"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0004",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "下列哪一項最符合 ACE inhibitor 在心血管系統的臨床益處（除降壓外）？",
    "options": [
      {
        "key": "A",
        "text": "促進心室重塑（remodeling）"
      },
      {
        "key": "B",
        "text": "降低前負荷與後負荷、減少心肌梗塞後不良重塑"
      },
      {
        "key": "C",
        "text": "增加交感活性以維持心輸出量"
      },
      {
        "key": "D",
        "text": "主要作用為增加血小板聚集"
      }
    ],
    "answer": "B",
    "explanation": "ACEi 可減少 preload/afterload，並在 MI 後減少不良心室重塑、保留左心室功能、延緩心衰進展，故常作為具適應症患者的重要藥物。",
    "tags": [
      "hypertension",
      "ACEi",
      "heart failure",
      "post-MI"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0005",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "對於『頑固型高血壓（resistant hypertension）』或懷疑原發性醛固酮增多症患者，加用下列何種藥物最有證據支持？",
    "options": [
      {
        "key": "A",
        "text": "Spironolactone"
      },
      {
        "key": "B",
        "text": "Digoxin"
      },
      {
        "key": "C",
        "text": "Short-acting nifedipine"
      },
      {
        "key": "D",
        "text": "Isosorbide dinitrate"
      }
    ],
    "answer": "A",
    "explanation": "Resistant HTN 常與醛固酮相關機轉有關；MRA（如 spironolactone）在頑固型高血壓與原發性醛固酮增多症常有效。",
    "tags": [
      "hypertension",
      "resistant hypertension",
      "MRA"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0006",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "下列何者屬於 dihydropyridine（DHP）類鈣離子阻斷劑（CCB），且相對較偏血管擴張作用？",
    "options": [
      {
        "key": "A",
        "text": "Verapamil"
      },
      {
        "key": "B",
        "text": "Diltiazem"
      },
      {
        "key": "C",
        "text": "Amlodipine"
      },
      {
        "key": "D",
        "text": "Ivabradine"
      }
    ],
    "answer": "C",
    "explanation": "DHP 類（如 amlodipine、felodipine、nifedipine）以血管擴張為主；verapamil、diltiazem 為 non-DHP，較偏抑制心傳導/降心率。",
    "tags": [
      "hypertension",
      "CCB",
      "pharmacology"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0007",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "非二氫吡啶（non-DHP）類 CCB 的共同特徵，下列何者正確？",
    "options": [
      {
        "key": "A",
        "text": "主要降低心率與房室結傳導"
      },
      {
        "key": "B",
        "text": "完全沒有負性變力作用"
      },
      {
        "key": "C",
        "text": "主要用於急性主動脈剝離第一線"
      },
      {
        "key": "D",
        "text": "常造成反射性心搏過速為主要副作用"
      }
    ],
    "answer": "A",
    "explanation": "Non-DHP（verapamil、diltiazem）可降低心率並抑制 AV node 傳導，具有負性變力作用；反射性心搏過速更常見於 DHP 類。",
    "tags": [
      "CCB",
      "arrhythmia",
      "pharmacology"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0008",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "關於 β 阻斷劑的 intrinsic sympathomimetic activity（ISA），下列敘述何者正確？",
    "options": [
      {
        "key": "A",
        "text": "有 ISA 的 β 阻斷劑通常更適合心肌梗塞後二級預防"
      },
      {
        "key": "B",
        "text": "ISA 代表藥物同時具有部分致效劑活性，較不會造成靜息心率過低"
      },
      {
        "key": "C",
        "text": "所有 β1 選擇性阻斷劑都具有 ISA"
      },
      {
        "key": "D",
        "text": "ISA 會增加死亡率因此臨床完全禁用"
      }
    ],
    "answer": "B",
    "explanation": "ISA 表示部分致效活性，靜息心率下降較少；在需強力抑制交感（如 MI 後）通常偏好無 ISA 的 β 阻斷劑。",
    "tags": [
      "beta blocker",
      "pharmacology"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0009",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "關於『兩側上臂收縮壓差（inter-arm difference）』的臨床意義，下列何者較恰當？",
    "options": [
      {
        "key": "A",
        "text": "差距越大越代表量測正常"
      },
      {
        "key": "B",
        "text": "一般而言差距若明顯增大，需考慮周邊動脈疾病或主動脈弓分支病變"
      },
      {
        "key": "C",
        "text": "只要舒張壓相同就不需理會"
      },
      {
        "key": "D",
        "text": "只與情緒緊張有關，無臨床意義"
      }
    ],
    "answer": "B",
    "explanation": "兩側上臂血壓差若明顯（常以 >10–15 mmHg 作為警訊），需考慮血管狹窄/周邊動脈疾病等。臨床上會以較高的一側作後續追蹤基準。",
    "tags": [
      "blood pressure measurement",
      "vascular disease"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0010",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "急性主動脈剝離（aortic dissection）初始藥物處置的核心原則為何？",
    "options": [
      {
        "key": "A",
        "text": "先給血管擴張劑降低血壓，β 阻斷劑可延後"
      },
      {
        "key": "B",
        "text": "先控制心率/收縮力（β 阻斷）以降低 dP/dt，再視需要加血管擴張劑"
      },
      {
        "key": "C",
        "text": "以利尿劑為第一線降低後負荷"
      },
      {
        "key": "D",
        "text": "以短效 nifedipine 舌下含服快速降壓"
      }
    ],
    "answer": "B",
    "explanation": "主動脈剝離急性期重點是降低剪力（shear stress）：先用 β 阻斷劑降低心率與 dP/dt，再視血壓加硝普鈉等血管擴張劑；避免單獨先給擴張劑造成反射性心搏過速。",
    "tags": [
      "aortic disease",
      "emergency",
      "hypertension"
    ]
  },
  
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0014",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 26 },
    "stem": "下列何者不是寬的脈搏壓（wide pulse pressure）要考慮的鑑別診斷？",
    "options": [
      { "key": "A", "text": "主動脈瓣狹窄 (aortic stenosis)" },
      { "key": "B", "text": "甲狀腺毒症 (thyrotoxicosis)" },
      { "key": "C", "text": "感染發燒" },
      { "key": "D", "text": "開放性動脈導管 (patent ductus arteriosus)" }
    ],
    "answer": "A",
    "explanation": "主動脈瓣狹窄通常造成『窄』脈搏壓，因射出受限使收縮壓不易上升。相反地，甲亢、發燒、PDA 等高心輸出/低周邊阻力或增加收縮壓情境較常見 wide pulse pressure。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0015",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 26 },
    "stem": "一位 26 歲女性患高血壓半年，近 3 個月出現心悸、頭痛、流汗。若欲給藥治療其高血壓，下列何者最適當？（疑嗜鉻細胞瘤）",
    "options": [
      { "key": "A", "text": "僅使用 α 阻斷劑 (alpha-adrenergic blocker)" },
      { "key": "B", "text": "僅使用 β 阻斷劑 (beta-adrenergic blocker)" },
      { "key": "C", "text": "鈣離子阻斷劑" },
      { "key": "D", "text": "先 α 阻斷，再加 β 阻斷" }
    ],
    "answer": "B",
    "explanation": "嗜鉻細胞瘤若單獨先給 β 阻斷劑，會造成未被抑制的 α 作用『相對占優勢』而使血壓更劇烈上升。正確原則是先 α 阻斷後必要時再加 β 阻斷。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0016",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 27 },
    "stem": "一位 27 歲女性長期追蹤高血壓，為育齡/可能懷孕族群。下列何者最不適合？",
    "options": [
      { "key": "A", "text": "methyldopa" },
      { "key": "B", "text": "長效型 calcium channel blocker" },
      { "key": "C", "text": "labetalol" },
      { "key": "D", "text": "ACE inhibitor" }
    ],
    "answer": "D",
    "explanation": "ACEI/ARB 具胎兒腎毒性與致畸胎風險，育齡女性/妊娠應避免；methyldopa、labetalol、部分 CCB（如 nifedipine）較常作為妊娠期可用選項。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0017",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 27 },
    "stem": "25 歲男性疑嗜鉻細胞瘤即將接受手術治療，下列處置何者最正確？",
    "options": [
      { "key": "A", "text": "立刻安排緊急手術切除" },
      { "key": "B", "text": "儘快安排 CT 導引腎上腺腫瘤切片" },
      { "key": "C", "text": "手術前 7–10 天先給予適量 α 阻斷劑並補充水分" },
      { "key": "D", "text": "立即給予體抑素類似物 (somatostatin analogue)" }
    ],
    "answer": "C",
    "explanation": "嗜鉻細胞瘤手術前需充分準備：先以 α 阻斷劑控制血壓並擴充血容量（補液），必要時再加 β 阻斷以控制心搏過速；避免穿刺活檢誘發兒茶酚胺危象。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0018",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 28 },
    "stem": "下列何種狀況不是使用 ACE inhibitor 的禁忌？",
    "options": [
      { "key": "A", "text": "腎功能持續惡化" },
      { "key": "B", "text": "低血鉀" },
      { "key": "C", "text": "懷孕" },
      { "key": "D", "text": "雙側腎動脈狹窄" }
    ],
    "answer": "B",
    "explanation": "ACEI 常見問題是『高血鉀』而不是低血鉀；懷孕、雙側腎動脈狹窄、腎功能惡化等需避免或慎用。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0019",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 28 },
    "stem": "當高血壓病人合併下列狀況時，何者較不支持次發性高血壓？",
    "options": [
      { "key": "A", "text": "抽血發現低血鉀" },
      { "key": "B", "text": "頭痛、心悸、盜汗" },
      { "key": "C", "text": "睡覺打鼾且白天嗜睡" },
      { "key": "D", "text": "高血脂症" }
    ],
    "answer": "D",
    "explanation": "低血鉀（考慮原發性醛固酮增多症）、三聯症狀（考慮嗜鉻細胞瘤）、打鼾嗜睡（考慮 OSA）都支持次發性高血壓；高血脂並非典型次發性線索。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0020",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 29 },
    "stem": "26 歲患者 BMI 20，健檢發現高血壓、低血鉀。評估次發性高血壓的檢查何者最適當？",
    "options": [
      { "key": "A", "text": "aldosterone 與 plasma renin activity" },
      { "key": "B", "text": "ACTH 與 cortisol" },
      { "key": "C", "text": "24 小時尿 VMA 與 catecholamines" },
      { "key": "D", "text": "free T4 與 TSH" }
    ],
    "answer": "A",
    "explanation": "高血壓合併低血鉀優先考慮原發性醛固酮增多症；初步檢查為 aldosterone/renin（比值）評估。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0021",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 29 },
    "stem": "測量血壓時由近心端往周邊逐次測量，下列敘述何者正確？",
    "options": [
      { "key": "A", "text": "收縮壓上升、舒張壓下降" },
      { "key": "B", "text": "收縮壓上升、舒張壓上升" },
      { "key": "C", "text": "收縮壓不變、舒張壓下降" },
      { "key": "D", "text": "收縮壓上升、舒張壓不變" }
    ],
    "answer": "A",
    "explanation": "越往周邊血管阻力與反射波影響增加，收縮壓通常較高；舒張壓受大血管回彈影響，往周邊相對較低。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0022",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 29 },
    "stem": "40 歲糖尿病患者，eGFR 59 mL/min/1.73m² 且尿蛋白 1.5 g/day，血壓 138/86 mmHg。下列處置何者最恰當？",
    "options": [
      { "key": "A", "text": "輔以低劑量長效型胰島素" },
      { "key": "B", "text": "使用紅血球生成素以減緩腎功能惡化" },
      { "key": "C", "text": "加用 ACEi/ARB（RAS blockade）" },
      { "key": "D", "text": "低蛋白飲食合併胺基酸補充品" }
    ],
    "answer": "C",
    "explanation": "糖尿病合併蛋白尿/CKD 者，優先使用 RAS blockade（ACEi 或 ARB）以降低蛋白尿並延緩腎功能惡化，血壓目標常較嚴格（依指南與個案）。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0023",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 30 },
    "stem": "65 歲男性換藥後出現腹脹與便秘，最可能使用下列何種降壓藥？",
    "options": [
      { "key": "A", "text": "Valsartan" },
      { "key": "B", "text": "Renitec (enalapril)" },
      { "key": "C", "text": "Labetalol" },
      { "key": "D", "text": "Amlodipine" }
    ],
    "answer": "D",
    "explanation": "鈣離子阻斷劑常見副作用包括便秘、周邊水腫等；臨床題幹以 amlodipine 作為選項。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0024",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 30 },
    "stem": "55 歲女性高血壓與糖尿病，近 3 個月乾咳，無呼吸道警訊，胸部 X 光正常。下列何者最重要？",
    "options": [
      { "key": "A", "text": "肺功能檢查" },
      { "key": "B", "text": "鼻竇 X 光檢查" },
      { "key": "C", "text": "詢問/確認是否使用 ACE inhibitor 等降壓藥" }
    ],
    "answer": "C",
    "explanation": "ACE inhibitor 典型副作用為乾咳；在排除警訊與影像正常時，需優先回顧用藥史。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0025",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 32 },
    "stem": "60 歲女性血壓 170/100 mmHg、BMI 27.1，平日睡前紅酒 30 mL。下列何者屬建議的生活型態改變？",
    "options": [
      { "key": "A", "text": "減輕體重" },
      { "key": "B", "text": "每日鈉攝取量控制（例如減鹽）" },
      { "key": "C", "text": "降低酒精攝取量" },
      { "key": "D", "text": "生活型態對血壓無實證支持" }
    ],
    "answer": "A",
    "explanation": "生活型態（體重、飲食鈉、酒精、運動）均與血壓有實證關聯；選項中以減重作為最佳單選答案（其餘亦屬可建議）。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0026",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 34 },
    "stem": "55 歲糖尿病男性，血壓 160/100 mmHg，尿蛋白 (+)，creatinine 1.0 mg/dL。起始降壓藥物何者較適當？",
    "options": [
      { "key": "A", "text": "利尿劑" },
      { "key": "B", "text": "ACEi/ARB" },
      { "key": "C", "text": "β 阻斷劑" },
      { "key": "D", "text": "methyldopa" }
    ],
    "answer": "B",
    "explanation": "糖尿病合併蛋白尿者，ACEi/ARB 可降低蛋白尿並提供腎保護效益，常作為優先選擇。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0027",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 34 },
    "stem": "下列何者是次發性高血壓最常見原因？",
    "options": [
      { "key": "A", "text": "腎實質疾病 (renal parenchymal disease)" },
      { "key": "B", "text": "原發性醛固酮增多症" },
      { "key": "C", "text": "嗜鉻細胞瘤" },
      { "key": "D", "text": "庫欣氏症候群" }
    ],
    "answer": "A",
    "explanation": "次發性高血壓最常見原因為腎實質疾病；其他如腎血管性、原發性醛固酮增多症、OSA 等亦常見但相對次之。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0028",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 34 },
    "stem": "58 歲男性無糖尿病/CKD，血壓 172/102 mmHg。血壓控制目標何者較適當？",
    "options": [
      { "key": "A", "text": "160/90 mmHg" },
      { "key": "B", "text": "140/90 mmHg" },
      { "key": "C", "text": "130/80 mmHg" },
      { "key": "D", "text": "120/80 mmHg" }
    ],
    "answer": "B",
    "explanation": "依題目所用教材/考題版本（台灣常見教法），無 DM/CKD 且未滿 60 歲之一般族群，目標多以 <140/90 mmHg 為基準（不同指南年份可能略有差異）。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0029",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 34 },
    "stem": "下列關於次發性高血壓的敘述，何者正確？",
    "options": [
      { "key": "A", "text": "原發性醛固酮增多症常合併高血鉀" },
      { "key": "B", "text": "最常見的次發性高血壓為腎實質病變" },
      { "key": "C", "text": "嗜鉻細胞瘤亦可發生於腎上腺外組織" },
      { "key": "D", "text": "睡眠呼吸障礙亦為次發性高血壓原因之一" }
    ],
    "answer": "A",
    "explanation": "原發性醛固酮增多症典型是低血鉀而非高血鉀；其餘敘述（腎實質病變最常見、嗜鉻細胞瘤可腎上腺外、OSA 相關）皆為正確概念，因此本題以 A 為錯誤選項。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0030",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 35 },
    "stem": "高血壓婦女懷孕時，下列哪項降壓藥不適合使用？",
    "options": [
      { "key": "A", "text": "α-methyldopa" },
      { "key": "B", "text": "labetalol" },
      { "key": "C", "text": "captopril" },
      { "key": "D", "text": "nifedipine" }
    ],
    "answer": "C",
    "explanation": "ACE inhibitor（如 captopril）為妊娠禁忌；methyldopa、labetalol、nifedipine 常作為妊娠期可用選項。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0031",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 35 },
    "stem": "24 歲女性早發且難控制高血壓，合併低血鉀。下列何者最可能？",
    "options": [
      { "key": "A", "text": "嗜鉻細胞瘤" },
      { "key": "B", "text": "庫欣氏症候群" },
      { "key": "C", "text": "先天性腎上腺增生" },
      { "key": "D", "text": "康氏症候群（Conn syndrome，原發性醛固酮增多症）" }
    ],
    "answer": "D",
    "explanation": "早發高血壓合併低血鉀應優先考慮原發性醛固酮增多症。庫欣/CAH 常伴雄性素或皮質醇相關表現；嗜鉻細胞瘤則以陣發性頭痛、心悸、盜汗較典型。"
  },

  {
    "id": "MED_03_CARD_PULM_DER_AORTA_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "section": "Aortic disease", "note": "derived from text" },
    "stem": "關於腹主動脈瘤（AAA）篩檢，下列何者最符合常見建議？",
    "options": [
      { "key": "A", "text": "所有 40 歲以上成人每年超音波篩檢" },
      { "key": "B", "text": "65–75 歲曾吸菸男性可考慮一次性腹部超音波篩檢" },
      { "key": "C", "text": "僅女性需要篩檢，男性不需" },
      { "key": "D", "text": "AAA 篩檢首選檢查是胸部 X 光" }
    ],
    "answer": "B",
    "explanation": "AAA 篩檢常見建議為：65–75 歲曾吸菸男性接受一次性腹部超音波（不同指南對女性/家族史族群有延伸建議）。超音波是首選篩檢工具。",
    "tags": ["aorta", "AAA", "screening"]
  },
  {
    "id": "MED_03_CARD_PULM_DER_AORTA_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "section": "Aortic disease", "note": "derived from text" },
    "stem": "急性主動脈剝離的降壓治療策略，下列何者正確？",
    "options": [
      { "key": "A", "text": "先用血管擴張劑降壓，再視需要加 β 阻斷劑" },
      { "key": "B", "text": "優先 β 阻斷劑降低心率與 dP/dt，再視血壓加血管擴張劑" },
      { "key": "C", "text": "優先利尿劑降低後負荷" },
      { "key": "D", "text": "以短效 nifedipine 舌下含服作為標準處置" }
    ],
    "answer": "B",
    "explanation": "剝離急性期核心是降低剪力：先 β 阻斷降低心率與 dP/dt，再用血管擴張劑輔助降壓；避免單獨先給擴張劑造成反射性心搏過速。",
    "tags": ["aortic dissection", "emergency", "blood pressure"]
  },
  {
    "id": "MED_03_CARD_PULM_DER_AORTA_Q0003",
    "source_type": "derived",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "section": "Aortic disease", "note": "derived from text" },
    "stem": "胸主動脈瘤（TAA）或 AAA 的破裂風險因子，下列何者最直接相關？",
    "options": [
      { "key": "A", "text": "瘤體直徑越大" },
      { "key": "B", "text": "血鈣越低" },
      { "key": "C", "text": "TSH 越高" },
      { "key": "D", "text": "血小板越多" }
    ],
    "answer": "A",
    "explanation": "主動脈瘤破裂風險最重要的臨床指標之一是直徑（以及成長速度）；直徑越大，破裂風險越高。",
    "tags": ["aneurysm", "risk"]
  },
  {
    "id": "MED_03_CARD_PULM_DER_AORTA_Q0004",
    "source_type": "derived",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "section": "Aortic disease", "note": "derived from text" },
    "stem": "主動脈剝離 Stanford 分型的描述，下列何者正確？",
    "options": [
      { "key": "A", "text": "Type A：不涉及升主動脈；Type B：涉及升主動脈" },
      { "key": "B", "text": "Type A：涉及升主動脈；Type B：不涉及升主動脈" },
      { "key": "C", "text": "Type A/B 只以是否合併高血壓區分" },
      { "key": "D", "text": "Type A/B 與 DeBakey 分型完全無關" }
    ],
    "answer": "B",
    "explanation": "Stanford Type A 只要涉及升主動脈即屬 Type A；Type B 為不涉及升主動脈的剝離（通常自左鎖骨下動脈遠端開始）。",
    "tags": ["aortic dissection", "classification"]
  },
  {
    "id": "MED_03_CARD_PULM_DER_AORTA_Q0005",
    "source_type": "derived",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "section": "Aortic disease", "note": "derived from text" },
    "stem": "急性主動脈剝離時常見的『影像/臨床線索』，下列何者較典型？",
    "options": [
      { "key": "A", "text": "撕裂樣胸背痛、兩側血壓差、縱隔增寬" },
      { "key": "B", "text": "黃疸合併茶色尿" },
      { "key": "C", "text": "慢性乾咳持續 3 個月" },
      { "key": "D", "text": "侷限性右下腹痛合併反跳痛" }
    ],
    "answer": "A",
    "explanation": "典型線索包括突發撕裂樣胸背痛、脈搏/血壓不對稱、胸部 X 光縱隔增寬；確診多依 CTA/TEE/MRI 視情況選用。",
    "tags": ["aortic dissection", "clinical"]
  },

  
  {
    "id": "MED3_V1_ORIG_PULM_BASIC_Q0001",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜胸部X光判讀" },
    "stem": "要診斷肺尖 (lung apices) 上的病灶，下列何種 X 光片的照法最為適當？",
    "options": [
      { "key": "A", "text": "PA view" },
      { "key": "B", "text": "lateral view" },
      { "key": "C", "text": "lateral decubitus view" },
      { "key": "D", "text": "lordotic view" }
    ],
    "answer": "D",
    "explanation": "Lordotic view 可減少鎖骨與第一、二肋骨對肺尖的遮蔽，提升肺尖病灶辨識度，因此最適合用來看肺尖病灶。 [oai_citation:4‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)"
  },
  {
    "id": "MED3_V1_ORIG_PULM_BASIC_Q0002",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜胸部X光判讀" },
    "stem": "50 歲男性主訴胸痛和咳嗽，胸部影像如圖（題本），最可能的診斷為下列何者？",
    "options": [
      { "key": "A", "text": "肺癌" },
      { "key": "B", "text": "侷限性肋膜積液" },
      { "key": "C", "text": "葉間積液 (interlobar effusion)" },
      { "key": "D", "text": "肺動脈栓塞 (pulmonary embolism)" }
    ],
    "answer": "A",
    "explanation": "題本詳解指出：可見 mass lesion 壓迫支氣管造成不規則狹窄；積液較不會造成此型態；肺栓塞梗塞較常呈外側 wedge-shaped 影像表現，因此選肺癌。 [oai_citation:5‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)"
  },
  {
    "id": "MED3_V1_DER_PULM_BASIC_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜症狀學鑑別" },
    "stem": "胸痛病患的初步鑑別診斷，下列哪一組屬於本書強調需優先排除的『四大急症』？",
    "options": [
      { "key": "A", "text": "心肌梗塞、主動脈剝離、高張性氣胸、心包膜填塞" },
      { "key": "B", "text": "肺癌、胃食道逆流、肋軟骨炎、帶狀皰疹" },
      { "key": "C", "text": "肺結核、COPD、氣喘、支氣管擴張" },
      { "key": "D", "text": "肺炎、肋膜積液、肺水腫、肺栓塞" }
    ],
    "answer": "A",
    "explanation": "本書在胸痛鑑別中明確提到需先排除四大急症：心肌梗塞、主動脈剝離、高張性氣胸、心包膜填塞。 [oai_citation:6‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["chest pain", "emergency", "differential"]
  },
  {
    "id": "MED3_V1_DER_PFT_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜肺功能" },
    "stem": "下列何者為本書對 COPD 的肺功能診斷門檻？",
    "options": [
      { "key": "A", "text": "FEV1/FVC < 70%" },
      { "key": "B", "text": "FEV1/FVC < 90%" },
      { "key": "C", "text": "TLC < 70% predicted" },
      { "key": "D", "text": "DLCO > 120% predicted" }
    ],
    "answer": "A",
    "explanation": "書中在肺量計段落寫明：阻塞性氣道阻塞與 COPD 的定義可用 FEV1/FVC < 70% 作為門檻。 [oai_citation:7‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["spirometry", "COPD", "diagnosis"]
  },
  {
    "id": "MED3_V1_DER_DLCO_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜肺功能" },
    "stem": "依本書：DLCO 下降較常見於下列哪一組情況？",
    "options": [
      { "key": "A", "text": "肺氣腫、間質性肺病、肺血管栓塞" },
      { "key": "B", "text": "肥胖、肺出血、心衰竭早期、氣喘" },
      { "key": "C", "text": "單純焦慮過度換氣" },
      { "key": "D", "text": "上呼吸道感染（鼻炎）" }
    ],
    "answer": "A",
    "explanation": "書中列舉：DLCO 在肺氣腫、間質性肺病、肺血管栓塞時會下降；在肥胖、肺出血、心衰竭早期、氣喘等血流量增加情境可上升。 [oai_citation:8‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["DLCO", "PFT", "differential"]
  },
  {
    "id": "MED3_V1_DER_ASTHMA_Q0006",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜肺功能" },
    "stem": "支氣管擴張劑可逆性試驗（bronchodilator reversibility test）陽性，依本書最符合的條件是？",
    "options": [
      { "key": "A", "text": "FEV1 增加 > 12% 且 > 200 mL" },
      { "key": "B", "text": "FEV1 增加 > 5% 且 > 50 mL" },
      { "key": "C", "text": "FEV1/FVC < 70% 即可視為陽性" },
      { "key": "D", "text": "DLCO 增加 > 10% 即可視為陽性" }
    ],
    "answer": "A",
    "explanation": "書中氣喘診斷段落：支氣管擴張劑可逆性試驗陽性為 FEV1 增加 >12% 且 >200 mL；若 >15% 且 >400 mL 更能確認診斷。 [oai_citation:9‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["asthma", "spirometry", "reversibility"]
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0007",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜題目" },
    "stem": "對於急性氣喘發作，下列何者藥物不是第一線的治療選項？",
    "options": [
      { "key": "A", "text": "β2 adrenergic agents" },
      { "key": "B", "text": "Anticholinergics" },
      { "key": "C", "text": "Corticosteroids" },
      { "key": "D", "text": "Theophylline" }
    ],
    "answer": "D",
    "explanation": "題本將急性發作第一線放在吸入型支氣管擴張劑（SABA）、抗膽鹼藥（視嚴重度加用）與全身性類固醇；theophylline 因治療窗窄、副作用與交互作用較多，通常不作急性發作第一線。題幹出處同題組。 [oai_citation:10‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)"
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0008",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜題目" },
    "stem": "下列關於氣喘 (bronchial asthma) 疾病的敘述，何者錯誤？",
    "options": [
      { "key": "A", "text": "呼吸道慢性發炎反應 (chronic inflammation)" },
      { "key": "B", "text": "呼吸道過度反應 (hyperresponsiveness)" },
      { "key": "C", "text": "多屬不可逆性的氣道阻塞 (irreversible airway obstruction)" },
      { "key": "D", "text": "屬異質性 (heterogeneous) 疾病，常是基因與環境因素交互作用所致" }
    ],
    "answer": "C",
    "explanation": "氣喘典型特徵是可變且多數可逆的氣流受限（尤其在早期/適當治療下），並非『多屬不可逆』；A、B、D 符合氣喘核心特徵（慢性發炎、氣道高反應、異質性與基因×環境交互）。 [oai_citation:11‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)"
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0009",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜題目" },
    "stem": "評估支氣管哮喘病患急性發作時，下列何種理學檢查結果不能作為哮喘嚴重度指標？",
    "options": [
      { "key": "A", "text": "使用輔助肌吸氣 (accessory muscle use)" },
      { "key": "B", "text": "使用噘嘴呼吸 (pursed-lip breathing)" },
      { "key": "C", "text": "胸腔過度充氣 (hyperinflation)" },
      { "key": "D", "text": "有奇異脈 (paradoxical pulse)" }
    ],
    "answer": "B",
    "explanation": "題本詳解：噘嘴呼吸屬於氣喘/COPD 的呼吸訓練技巧，並非急性惡化的嚴重度表徵；其餘如輔助肌使用、過度充氣、奇異脈可見於嚴重發作評估情境。 [oai_citation:12‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)"
  },
  {
    "id": "MED3_V1_DER_ASTHMA_Q0010",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜病史詢問" },
    "stem": "下列哪一項病史特徵『較不像』典型氣喘？",
    "options": [
      { "key": "A", "text": "症狀在半夜或清晨惡化" },
      { "key": "B", "text": "症狀隨時間變化，且可被病毒感染/運動/過敏原誘發" },
      { "key": "C", "text": "只有咳嗽、沒有其他呼吸道症狀" },
      { "key": "D", "text": "咳、喘、胸悶、喘鳴多種症狀並存" }
    ],
    "answer": "C",
    "explanation": "書中指出：只有咳嗽而無其他呼吸道症狀時，需優先考慮 post-nasal drip 或 GERD；其餘選項皆是偏向氣喘的典型病史特徵。 [oai_citation:13‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["asthma", "history", "differential"]
  },
  {
    "id": "MED3_V1_DER_ASTHMA_Q0011",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜病史詢問" },
    "stem": "慢性痰多（chronic sputum production）合併呼吸道症狀時，依本書較應優先考慮哪一組診斷？",
    "options": [
      { "key": "A", "text": "COPD 或支氣管擴張" },
      { "key": "B", "text": "單純氣喘" },
      { "key": "C", "text": "心因性過度換氣" },
      { "key": "D", "text": "急性肺栓塞" }
    ],
    "answer": "A",
    "explanation": "書中在『較不像氣喘』的病史列出：慢性痰多需考慮 COPD 或支氣管擴張。 [oai_citation:14‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["sputum", "COPD", "bronchiectasis"]
  },

  
  {
    "id": "MED3_V1_DER_COPD_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜診斷" },
    "stem": "COPD 的肺功能診斷最核心的條件為何？",
    "options": [
      { "key": "A", "text": "FEV1/FVC < 0.70（支氣管擴張劑後）" },
      { "key": "B", "text": "DLCO > 120% predicted" },
      { "key": "C", "text": "TLC < 80% predicted" },
      { "key": "D", "text": "FEV1 > 80% predicted 即可確診" }
    ],
    "answer": "A",
    "explanation": "COPD 的關鍵是『持續性氣流受限』，以支氣管擴張劑後 FEV1/FVC < 0.70 作為典型診斷門檻。TLC 下降偏限制型；DLCO 上升非 COPD 典型。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜病理生理" },
    "stem": "下列何者最符合肺氣腫（emphysema）造成氣流受限的主要機轉？",
    "options": [
      { "key": "A", "text": "肺泡壁破壞導致彈性回縮力下降與小氣道塌陷" },
      { "key": "B", "text": "支氣管平滑肌痙攣為主，完全可逆" },
      { "key": "C", "text": "肺泡毛細血管充血使 DLCO 上升" },
      { "key": "D", "text": "胸水增加導致 FEV1/FVC 上升" }
    ],
    "answer": "A",
    "explanation": "肺氣腫的核心是肺泡結構破壞 → 彈性回縮力下降 → 呼氣期小氣道易塌陷與 air trapping，造成不可完全逆轉的氣流受限。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜鑑別" },
    "stem": "下列何者較支持『COPD』而非『氣喘』？",
    "options": [
      { "key": "A", "text": "中老年、長期吸菸史、症狀持續且可逆性較差" },
      { "key": "B", "text": "症狀明顯日夜變動、清晨/半夜加劇、可逆性高度陽性" },
      { "key": "C", "text": "FEV1 增加 >12% 且 >200 mL（支擴後）是典型 COPD" },
      { "key": "D", "text": "DLCO 一定上升" }
    ],
    "answer": "A",
    "explanation": "COPD 常見於中老年且與吸菸高度相關，症狀較持續且支擴後可逆性較差；氣喘常見症狀變動、夜間/清晨加劇，且可逆性試驗陽性更支持氣喘。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜急性惡化處置" },
    "stem": "COPD 急性惡化（AECOPD）第一線『支氣管擴張』用藥組合最典型為何？",
    "options": [
      { "key": "A", "text": "吸入 SABA（如 albuterol）± 吸入 SAMA（如 ipratropium）" },
      { "key": "B", "text": "theophylline 單方" },
      { "key": "C", "text": "吸入 ICS 單方" },
      { "key": "D", "text": "長效 β2 刺激劑（LABA）起始即可取代所有短效藥" }
    ],
    "answer": "A",
    "explanation": "AECOPD 急性期以短效支氣管擴張劑為主：SABA ± SAMA；theophylline 治療窗窄不作首選；ICS 單方不適合急性期立即救急。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜急性惡化處置" },
    "stem": "AECOPD 使用全身性類固醇的典型建議劑量/療程為何？",
    "options": [
      { "key": "A", "text": "Prednisone 40 mg/day 約 5 天（或等效劑量）" },
      { "key": "B", "text": "Prednisone 5 mg/day 連續 6 個月" },
      { "key": "C", "text": "僅在同時有蕁麻疹時才使用" },
      { "key": "D", "text": "必須靜脈高劑量 methylprednisolone 500 mg/day 連續 14 天" }
    ],
    "answer": "A",
    "explanation": "AECOPD 給予短療程全身性類固醇可改善肺功能與症狀、降低治療失敗；常用 prednisone 40 mg/day 5 天（或等效）。長期低劑量或高劑量長療程副作用大且不必要。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0006",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜急性惡化處置" },
    "stem": "AECOPD 何時較需要考慮抗生素治療？",
    "options": [
      { "key": "A", "text": "痰量增加、痰變膿、呼吸困難加劇（Anthonisen 三症狀）或需機械通氣" },
      { "key": "B", "text": "只要有咳嗽就一定要抗生素" },
      { "key": "C", "text": "只要胸部 X 光正常就一定不需要抗生素" },
      { "key": "D", "text": "僅在白血球 > 20,000 才需要" }
    ],
    "answer": "A",
    "explanation": "AECOPD 抗生素通常在細菌感染可能性高時使用：三大症狀（呼吸困難、痰量增加、痰膿性）或需要（非侵襲/侵襲）通氣支持者。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0007",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜氧氣與通氣" },
    "stem": "AECOPD 給氧治療的目標血氧飽和度（SpO2）最常建議為何？",
    "options": [
      { "key": "A", "text": "88–92%" },
      { "key": "B", "text": "100% 以避免缺氧" },
      { "key": "C", "text": "70–75% 以避免 CO2 retention" },
      { "key": "D", "text": "不需監測，給越多越好" }
    ],
    "answer": "A",
    "explanation": "COPD 可能有慢性高碳酸血症；急性惡化給氧目標通常 88–92% 以兼顧氧合與避免過度給氧導致 CO2 retention/酸中毒風險。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0008",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜氧氣與通氣" },
    "stem": "AECOPD 何者最符合啟動非侵襲性正壓通氣（NIV）的典型指徵？",
    "options": [
      { "key": "A", "text": "呼吸性酸中毒（如 pH < 7.35）且 PaCO2 升高" },
      { "key": "B", "text": "單純鼻塞" },
      { "key": "C", "text": "單純發燒但呼吸正常" },
      { "key": "D", "text": "pH 7.50（呼吸性鹼中毒）且 PaCO2 下降" }
    ],
    "answer": "A",
    "explanation": "NIV 對 AECOPD 合併高碳酸血症與呼吸性酸中毒最有實證效益，可降低插管率與死亡率。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0009",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜長期治療" },
    "stem": "長期氧療（LTOT）在穩定 COPD 的典型適應症為何？",
    "options": [
      { "key": "A", "text": "PaO2 ≤ 55 mmHg 或 SaO2 ≤ 88%（穩定狀態），或 PaO2 56–59 合併肺高壓/右心衰/紅血球增多" },
      { "key": "B", "text": "只要有喘就應該 24 小時給氧" },
      { "key": "C", "text": "只要 DLCO 下降就必須 LTOT" },
      { "key": "D", "text": "只要 FEV1 < 80% 就必須 LTOT" }
    ],
    "answer": "A",
    "explanation": "LTOT 的死亡率獲益主要在嚴重慢性低氧血症族群；條件通常以 PaO2/SaO2 門檻（及合併右心衰/肺高壓/紅血球增多等）判定。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0010",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜特殊病因" },
    "stem": "年輕（<45 歲）或下葉為主之肺氣腫、非典型吸菸史者，應考慮哪個可檢驗的特殊病因？",
    "options": [
      { "key": "A", "text": "α1-antitrypsin deficiency" },
      { "key": "B", "text": "G6PD deficiency" },
      { "key": "C", "text": "sickle cell disease" },
      { "key": "D", "text": "Gilbert syndrome" }
    ],
    "answer": "A",
    "explanation": "α1-antitrypsin deficiency 會造成較早發的肺氣腫（常為 panacinar，偏下葉），遇到年輕或不符吸菸量的病人要想到並檢驗。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0011",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜藥物策略" },
    "stem": "下列哪一項最符合 roflumilast 的典型使用情境？",
    "options": [
      { "key": "A", "text": "慢性支氣管炎表現、重度氣流受限且反覆急性惡化者（作為降低惡化策略之一）" },
      { "key": "B", "text": "急性發作第一線立即救急用藥" },
      { "key": "C", "text": "所有 COPD 病人都必須使用" },
      { "key": "D", "text": "只用於肺炎的抗生素替代品" }
    ],
    "answer": "A",
    "explanation": "Roflumilast（PDE-4 inhibitor）主要用在部分高風險 COPD（特別慢性支氣管炎表型、重度、反覆惡化）以降低惡化頻率；不是急性救急藥。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0012",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜ICS 適應症概念" },
    "stem": "COPD 長期治療中，何者較支持加用吸入型類固醇（ICS）（通常以 ICS/LABA 或 triple therapy）？",
    "options": [
      { "key": "A", "text": "反覆惡化且嗜酸性球偏高／或有明顯氣喘重疊特徵" },
      { "key": "B", "text": "只有單次輕微咳嗽" },
      { "key": "C", "text": "沒有惡化史且症狀很輕" },
      { "key": "D", "text": "只因為 DLCO 下降" }
    ],
    "answer": "A",
    "explanation": "ICS 在 COPD 的主要角色是降低部分病人的惡化風險，特別是反覆惡化且血嗜酸性球較高、或有氣喘重疊者；單純輕症或無惡化史不一定需要，且 ICS 會增加肺炎風險。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0013",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜非藥物治療" },
    "stem": "下列何者是 COPD 具有最大長期預後效益、且所有吸菸者都應積極執行的介入？",
    "options": [
      { "key": "A", "text": "戒菸（含行為治療與藥物輔助）" },
      { "key": "B", "text": "每日預防性口服類固醇" },
      { "key": "C", "text": "每週靜脈抗生素" },
      { "key": "D", "text": "長期使用短效 β2 刺激劑單方" }
    ],
    "answer": "A",
    "explanation": "戒菸是 COPD 最關鍵的疾病修正介入，可降低肺功能下降速度並改善長期預後；其他選項不是標準或風險遠大於獲益。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0014",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜併發症" },
    "stem": "COPD 併發肺高壓/右心衰（cor pulmonale）時，較可能出現下列哪個臨床表現？",
    "options": [
      { "key": "A", "text": "下肢水腫、頸靜脈怒張、肝腫大" },
      { "key": "B", "text": "侷限性右下腹反跳痛" },
      { "key": "C", "text": "黃疸合併灰白便" },
      { "key": "D", "text": "腦膜刺激徵" }
    ],
    "answer": "A",
    "explanation": "慢性缺氧導致肺血管收縮與重塑可形成肺高壓，進而造成右心負荷增加與右心衰，典型表現為 JVD、周邊水腫、肝腫大等。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0015",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜鑑別與影像" },
    "stem": "下列哪一項胸部影像/生理特徵較符合肺氣腫（emphysema）而非慢性支氣管炎（chronic bronchitis）？",
    "options": [
      { "key": "A", "text": "過度充氣、橫膈變平、DLCO 下降較明顯" },
      { "key": "B", "text": "長期咳痰為主，DLCO 多正常" },
      { "key": "C", "text": "一定合併大量胸水" },
      { "key": "D", "text": "一定合併雙側肺門淋巴結腫大" }
    ],
    "answer": "A",
    "explanation": "肺氣腫常見 air trapping/過度充氣與橫膈變平，且因肺泡-毛細血管床破壞導致 DLCO 下降；慢性支氣管炎則以咳痰為主、DLCO 常較保留。"
  },

  
  {
    "id": "MED3_V1_DER_ILD_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 間質性肺病（ILD）｜總論" },
    "stem": "典型 ILD 的肺功能型態最常見為何？",
    "options": [
      { "key": "A", "text": "限制型：TLC 下降、FVC 下降，FEV1/FVC 正常或上升" },
      { "key": "B", "text": "阻塞型：FEV1/FVC 下降為主" },
      { "key": "C", "text": "完全正常肺功能" },
      { "key": "D", "text": "只會造成 DLCO 上升" }
    ],
    "answer": "A",
    "explanation": "ILD 以肺實質/間質受損為主，典型呈限制型通氣障礙（TLC、FVC 下降），FEV1/FVC 常正常或相對上升；DLCO 多下降而非上升。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜氣體交換" },
    "stem": "下列何者最常見於多數 ILD 的氣體交換異常？",
    "options": [
      { "key": "A", "text": "DLCO 下降" },
      { "key": "B", "text": "DLCO 上升" },
      { "key": "C", "text": "A–a gradient 一定正常" },
      { "key": "D", "text": "只會造成 PaCO2 上升、PaO2 正常" }
    ],
    "answer": "A",
    "explanation": "ILD 造成肺泡-微血管膜受損與肺血管床減少，最典型是 DLCO 下降，且常見運動時低氧與 A–a gradient 增加。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜身體檢查" },
    "stem": "下列哪一組身體檢查較符合纖維化型 ILD（例如 IPF）？",
    "options": [
      { "key": "A", "text": "吸氣末乾囉音（Velcro crackles）± 杵狀指" },
      { "key": "B", "text": "單側胸膜摩擦音合併高熱" },
      { "key": "C", "text": "典型哮鳴音為主且完全可逆" },
      { "key": "D", "text": "只有鼻塞與流鼻水" }
    ],
    "answer": "A",
    "explanation": "纖維化型 ILD 常見雙側吸氣末細碎乾囉音（Velcro-like crackles），部分患者可見杵狀指；哮鳴音更像氣喘/COPD。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜影像學" },
    "stem": "ILD 評估中，最能用來辨識纖維化型態（如 UIP pattern）的影像檢查為何？",
    "options": [
      { "key": "A", "text": "高解析度胸部電腦斷層（HRCT）" },
      { "key": "B", "text": "單純 PA chest X-ray 即可確診分型" },
      { "key": "C", "text": "腹部超音波" },
      { "key": "D", "text": "心電圖" }
    ],
    "answer": "A",
    "explanation": "HRCT 是 ILD 分型與判斷纖維化樣態（UIP、NSIP、HP 等）的核心工具；CXR 常不足以分型。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜UIP/IPF" },
    "stem": "典型 UIP（usual interstitial pneumonia）在 HRCT 的最代表性特徵組合為何？",
    "options": [
      { "key": "A", "text": "周邊/胸膜下為主、基底部優勢的網狀影（reticulation）＋蜂窩肺（honeycombing）± traction bronchiectasis" },
      { "key": "B", "text": "中央型為主的肺門淋巴結腫大" },
      { "key": "C", "text": "瀰漫性樹芽徵（tree-in-bud）為主" },
      { "key": "D", "text": "大量胸水為主" }
    ],
    "answer": "A",
    "explanation": "UIP 的典型影像是胸膜下/周邊、基底部優勢的纖維化表現（reticulation、traction bronchiectasis）並常見 honeycombing。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0006",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜IPF 治療" },
    "stem": "下列何者屬於 IPF（idiopathic pulmonary fibrosis）具疾病修正效果、常用的抗纖維化藥物？",
    "options": [
      { "key": "A", "text": "Nintedanib 或 Pirfenidone" },
      { "key": "B", "text": "吸入 SABA（albuterol）單用" },
      { "key": "C", "text": "長期高劑量全身性類固醇作為標準治療" },
      { "key": "D", "text": "Warfarin 作為標準抗纖維化治療" }
    ],
    "answer": "A",
    "explanation": "IPF 的疾病修正治療以抗纖維化藥物（nintedanib、pirfenidone）為主，可減緩肺功能下降；常規長期高劑量類固醇不作為 IPF 標準治療。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0007",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜急性惡化" },
    "stem": "已知 IPF 病人突然在數天到數週內呼吸快速惡化、影像出現新發廣泛磨玻璃陰影（ground-glass opacities），最符合下列何者？",
    "options": [
      { "key": "A", "text": "IPF 急性惡化（acute exacerbation）" },
      { "key": "B", "text": "單純慢性穩定期變化" },
      { "key": "C", "text": "一定是肺癌轉移" },
      { "key": "D", "text": "一定是氣胸" }
    ],
    "answer": "A",
    "explanation": "IPF 急性惡化典型是短期內呼吸惡化，HRCT 可見在既有纖維化背景上新發的雙側磨玻璃/實變，需積極排除感染、心衰、肺栓塞等。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0008",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜NSIP vs UIP 概念" },
    "stem": "下列何者較偏向 NSIP（nonspecific interstitial pneumonia）而非典型 UIP？",
    "options": [
      { "key": "A", "text": "相對較均勻的磨玻璃陰影與纖維化、蜂窩肺較少見" },
      { "key": "B", "text": "明顯胸膜下基底部蜂窩肺為主" },
      { "key": "C", "text": "樹芽徵為主" },
      { "key": "D", "text": "大量胸水為主" }
    ],
    "answer": "A",
    "explanation": "NSIP 常呈較均勻的炎症/纖維化分布，ground-glass 相對多、honeycombing 較少；UIP 則常見胸膜下基底部為主的 honeycombing。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0009",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜過敏性肺炎（HP）" },
    "stem": "過敏性肺炎（hypersensitivity pneumonitis）最關鍵的病史線索為何？",
    "options": [
      { "key": "A", "text": "反覆接觸特定抗原（如鳥類、黴菌、農業/加濕器）後出現呼吸症狀" },
      { "key": "B", "text": "長期抽菸且咳痰為主" },
      { "key": "C", "text": "單次暴露粉塵後立即大量咳血" },
      { "key": "D", "text": "只有夜間喘鳴、完全可逆" }
    ],
    "answer": "A",
    "explanation": "HP 是免疫反應導致的間質性肺病，診斷核心是『明確的抗原暴露史』與其時間相關性；處置重點之一也包含避免暴露。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0010",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜結節病（Sarcoidosis）" },
    "stem": "下列哪個組合較典型支持結節病（sarcoidosis）？",
    "options": [
      { "key": "A", "text": "雙側肺門淋巴結腫大（BHL）± 非乾酪性肉芽腫" },
      { "key": "B", "text": "胸膜下基底部蜂窩肺為主" },
      { "key": "C", "text": "大量膿痰合併 lobar consolidation" },
      { "key": "D", "text": "只要 DLCO 下降就可診斷 sarcoidosis" }
    ],
    "answer": "A",
    "explanation": "Sarcoidosis 常見影像為雙側肺門淋巴結腫大，病理為非乾酪性肉芽腫；診斷需臨床＋影像＋（必要時）組織學與排除其他肉芽腫疾病。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0011",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜藥物性肺損傷" },
    "stem": "下列哪一組藥物與 ILD/間質性肺炎風險的關聯最典型？",
    "options": [
      { "key": "A", "text": "Amiodarone、Bleomycin、Nitrofurantoin" },
      { "key": "B", "text": "Metformin、Aspirin、Acetaminophen" },
      { "key": "C", "text": "Omeprazole、Famotidine、Aluminum hydroxide" },
      { "key": "D", "text": "Loratadine、Cetirizine、Fexofenadine" }
    ],
    "answer": "A",
    "explanation": "Amiodarone、bleomycin、nitrofurantoin 等是常被考的藥物性肺損傷/間質性肺炎原因；遇到 ILD 病人務必回顧用藥史。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0012",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜職業暴露" },
    "stem": "下列哪一項職業/環境暴露與特定 ILD（塵肺症）配對最合理？",
    "options": [
      { "key": "A", "text": "石綿（asbestos）→ 胸膜斑塊/石綿肺（asbestosis）" },
      { "key": "B", "text": "花粉暴露 → 矽肺（silicosis）" },
      { "key": "C", "text": "冷空氣 → 石綿肺" },
      { "key": "D", "text": "咖啡因 → 煤工塵肺（CWP）" }
    ],
    "answer": "A",
    "explanation": "石綿暴露與 asbestosis、胸膜斑塊、（並增加惡性間皮瘤/肺癌風險）是經典考點；矽肺多見於採礦/砂石噴砂等矽粉塵暴露。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0013",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜自體免疫關聯" },
    "stem": "下列哪一項最符合『結締組織疾病相關 ILD（CTD-ILD）』的臨床情境？",
    "options": [
      { "key": "A", "text": "ILD 合併 Raynaud 現象、關節痛/皮疹或特定自體抗體" },
      { "key": "B", "text": "單純反覆上呼吸道感染" },
      { "key": "C", "text": "只有偶發咳嗽，無其他系統症狀" },
      { "key": "D", "text": "只有胸痛，無呼吸道症狀" }
    ],
    "answer": "A",
    "explanation": "CTD-ILD 常見於 RA、systemic sclerosis、myositis、SLE 等背景；辨識點是 ILD 合併系統性自體免疫線索與血清學支持。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0014",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜鑑別陷阱" },
    "stem": "下列哪一項更像『心因性/循環性』而非 ILD 主要表現？",
    "options": [
      { "key": "A", "text": "運動喘合併雙下肢水腫與端坐呼吸" },
      { "key": "B", "text": "進行性運動喘合併吸氣末乾囉音" },
      { "key": "C", "text": "DLCO 下降與限制型肺功能" },
      { "key": "D", "text": "HRCT 出現周邊基底部纖維化" }
    ],
    "answer": "A",
    "explanation": "端坐呼吸與周邊水腫更支持心衰/循環系統問題；ILD 則偏向限制型肺功能、DLCO 下降、乾囉音與 HRCT 纖維化所見。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0015",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜處置原則" },
    "stem": "對多數疑似 ILD 病人，下列哪一項是最通用且重要的第一步策略？",
    "options": [
      { "key": "A", "text": "系統性釐清暴露史（職業/環境/藥物）＋安排 HRCT 與肺功能（含 DLCO）" },
      { "key": "B", "text": "直接長期高劑量類固醇，不需診斷分型" },
      { "key": "C", "text": "只做 CXR 即可，不需 HRCT" },
      { "key": "D", "text": "只要咳嗽就先開抗生素 4 週" }
    ],
    "answer": "A",
    "explanation": "ILD 的關鍵在『分類與找原因』：暴露史（藥物/職業/抗原）常直接決定診斷與治療；HRCT 與 PFT（含 DLCO）是基礎評估工具，必要時再進一步做血清學、BAL 或肺活檢。"
  }


]
